Cargando…
Effect of spironolactone on cardiovascular morbidity and mortality in patients with hypertension and glucose metabolism disorders (ESCAM): a study protocol for a pragmatic randomised controlled trial
INTRODUCTION: Hypertension combined with diabetes and hypokalemia is more likely to develop hyperaldosteronism and is at higher risk of cardiovascular events. There is evidence that activation of aldosterone and mineralocorticoid receptors may play a significant role in the occurrence of cardiovascu...
Autores principales: | Li, Nanfang, Lin, Mengyue, Heizhati, Mulalibieke, Wang, Lin, Luo, Qin, Li, Yuanyuan, Yili, Jina, Hong, Jing, Yao, Xiaoguang, Zhu, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678363/ https://www.ncbi.nlm.nih.gov/pubmed/33444188 http://dx.doi.org/10.1136/bmjopen-2020-038694 |
Ejemplares similares
-
Chinese Visceral Adiposity Index Is Associated With Incident Renal Damage in Patients With Hypertension and Abnormal Glucose Metabolism: A Longitudinal Study
por: Lin, Mengyue, et al.
Publicado: (2022) -
Higher plasma renin activity is associated with increased kidney damage risk in patients with hypertension and glucose metabolic disorders
por: Lin, Mengyue, et al.
Publicado: (2022) -
Development and Validation of a Prediction Model for 5-Year Risk of Kidney Dysfunction in Patients with Hypertension and Glucose Metabolism Disorder
por: Lin, Mengyue, et al.
Publicado: (2022) -
Higher plasma aldosterone is associated with increased risk of cardiovascular events in hypertensive patients with suspected OSA: UROSAH data
por: Gan, Lin, et al.
Publicado: (2022) -
Higher aldosterone is associated with increased renal impairment risk in patients with hypertension and abnormal glucose metabolism: a longitudinal study
por: Lin, Mengyue, et al.
Publicado: (2022)